06
Recently, the Recombinant Human nsIL12 Oncolytic Adenovirus Injection has obtained the approval by the NMPA for the clinical trial of Class I new drugs. The injection was jointly developed by the research team of Prof. Wang Pengju and Academician Nick Lemmon from the Sino-British Molecular Oncology Research Center of ZZU, and the International Joint Research Center of National Cell and Gene The...
19
The first ChinaNanoenzyme Summit Forumhas recentlyopened in Zhengzhou, Henan Province.Experts and scholars in this fieldattended the Summit, among whom were professorYan XiyunandChen Runshengwho arealsoacademiciansof Chinese Academy of Sciences,Li Ming, member of the Royal Society of Canada
15
Professor Jiang Binghua from School of Medical Scienceshasmade new progress inhis research onnon-small-cell lung carcinoma resistance.The research result, entitled "Elevated NOX4 Promotes Tumorigenesis and Acquired EGFR-TKIs Resistance via Enhancing IL-8/PD-L1 Signaling in NSCLC"is published in theleadingacademic journalDrug Resistance Updates
09
School of Chemical Engineering oftheUniversity has madeprogress in the field of all-solid lithium metal batteries. The related results are published,entitled“One Stone, Three Birds: An Air and Interface Stable Argyrodite Solid Electrolyte with Multifunctional Nanoshells”,in the internationaljournalAdvanced Science
Internal
E-mail
Jobs
中文
